Install App Extra 10% Off on APP


Schwabe News Volume 1 | Issue 1 | October 2010


As conveyed in an earlier message, we bring the first issue of our news letter, ‘Schwabe News’. As a responsible homoeopathic concern it is always our effort to pass on the recent developments in the field of homoeopathy along with the existing valuable information to you. In this issue we have covered an important development in field of homoeopathy. Department of AYUSH, Government of India has set up a dedicated call centre in Delhi to provide information to the public on homoeopathy and other Indian system of medicines.

Many rare drugs are known for its action in mother tincture and low potencies, but are less known for their efficacy in higher potency. A drug widely used as mother tincture for gastrointestinal and genitourinary problems, Agave americana, has a recent proving, which is given under Materia medica. We are sure that this would explore the curability of this drug which would be useful to physicians. If you find a case indicated to this drugs, please note that this drug is available with Schwabe India as mother tincture and in 6, 30, 200 and 1M.

Under ‘mother tincture info’, scientific information on ‘Ammi visnaga’ is given. Growing demand for this drug in mother tincture has lead to give such information. 

Present environment and lifestyle are the cause and concern for many new diseases and make many rare diseases into common ones, such as Hypothyroidism. Thyroidinum 3x has a role in managing the symptoms of hypothyroidism. Indication and other details of Thyroidinum 3x are given under ‘product watch’. It is now available in a new attractive pack from Schwabe India.

Under Research News, we have reported a new large scale homoeoprophylaxis clinical trial on leptospirosis, which was published in the journal ‘Homeopathy’ [formerly ‘British Homeopathic Journal’]. According to the study, the results are encouraging and this study once again proves that homoeopathy can contribute a lot in epidemics where large number of people is affected.

Enjoy reading and don’t miss to reply back with your feedback.


Dr. R. Valavan, BHMS, MD (Hom)